Vaccinex, Inc.
VCNX · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $4 | $27 | $30 |
| - Cash | $1 | $2 | $6 | $9 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $3 | $21 | $22 |
| Revenue | $1 | $1 | $0 | $1 |
| % Growth | 5.4% | 470% | -88.9% | – |
| Gross Profit | $1 | $1 | $0 | $1 |
| % Margin | 100% | 100% | 68% | 81.2% |
| EBITDA | -$19 | -$20 | -$20 | -$21 |
| % Margin | -3,084.5% | -3,464.6% | -19,606% | -2,378% |
| Net Income | -$19 | -$20 | -$20 | -$22 |
| % Margin | -3,100.5% | -3,552.8% | -19,722% | -2,486.7% |
| EPS Diluted | -8.88 | -43.68 | -97.59 | -162.91 |
| % Growth | 79.7% | 55.2% | 40.1% | – |
| Operating Cash Flow | -$16 | -$17 | -$19 | -$25 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$16 | -$17 | -$19 | -$25 |